bucladesine has been researched along with Parotid Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krause, G; Kumar, R; Meyers, A; Prasad, KN | 1 |
Bando, T; Nagamine, S; Sato, M; Yanagawa, T; Yoshida, H; Yura, Y | 1 |
2 other study(ies) available for bucladesine and Parotid Neoplasms
Article | Year |
---|---|
Effect of adenosine 3',5'-cyclic monophosphate (cAMP) on human non-tumorigenic and tumorigenic parotid acinar cells in culture.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenoma, Pleomorphic; Alprostadil; Bucladesine; Cell Differentiation; Cell Division; Cell Size; Cell Transformation, Neoplastic; Cells, Cultured; Colforsin; Cyclic AMP; Humans; Parotid Gland; Parotid Neoplasms; Phosphodiesterase Inhibitors; Receptors, Prostaglandin E; Tumor Cells, Cultured | 1996 |
Induction of cells with phenotypic features of neuronal cells by treatment with dibutyryl cyclic adenosine 3',5'-monophosphate in a human parotid gland adenocarcinoma cell line in culture.
Topics: Adenocarcinoma; Amylases; Bucladesine; Cytoskeleton; Fluorescent Antibody Technique; Humans; Intermediate Filaments; Parotid Neoplasms; Phenotype; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vasoactive Intestinal Peptide | 1990 |